Bioequivalence of Two Formulations of Levothyroxine Sodium 200 Micrograms (mcg) Under Tablet Form
Clinical trial NCT04037748 · COMPLETED
Trial details
- NCT number
- NCT04037748
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2019-09-11
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.